Cardiovascular Risk Factors and Atherosclerotic Cardiovascular Events Among Incident Cases of Systemic Sclerosis: Results From a Population-Based Cohort (1980-2016)
Reto Kurmann(Mayo Clinic), Ashima Makol(Mayo Clinic), Eric L. Matteson(Mayo Clinic), Cynthia S. Crowson(Mayo Clinic), Kenneth J Warrington(Mayo Clinic in Arizona), Thomas G. Osborn(Mayo Clinic in Arizona), Avneek Singh Sandhu(Mayo Clinic in Arizona), Rekha Mankad(Mayo Clinic in Arizona)
Cited by 33
Related Papers
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
|Arthritis & Rheumatology|2015|2.8k
2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
|Arthritis Care & Research|2012|1.8k
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
|Arthritis Care & Research|2015|1.1k